IQVIA Holdings Inc. IQV is set to release its third-quarter 2025 results on Oct. 28, before market open. IQV has a decent ...

IQVIA Holdings has seen its consensus analyst price target rise slightly to $223 from $218, reflecting a modest uptick in ...

Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund’s Investor ...

IQVIA Holdings is gearing up to release its third-quarter earnings later this month, and analysts project a steady ...

IQVIA Holdings, Inc. IQV is scheduled to release its first-quarter 2024 results on May 2, before market open. IQV has an impressive earnings surprise history, having surpassed the Zacks Consensus ...

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, ...

Shares of IQVIA Holdings Inc. advanced 3.67% to $212.05 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.07% to 6,735.13 and the ...

Shares of Scienture Holdings, Inc. (NASDAQ: SCNX) are rising Thursday after the company announced the start of commercial ...

Broyhill Asset Management, an investment advisor, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Broyhill Partners appreciated 3.7% net of all fees and ...

IQVIA Holdings, Inc. IQV is scheduled to release its fourth-quarter 2023 results on Feb 14 before market open. IQV has an impressive earnings surprise history, having surpassed the Zacks Consensus ...